Association of NOS1AP variants and depression phenotypes in schizophrenia

Journal of Affective Disorders

Volumn 188, Issue , 2015, Pages 263-269

  Cheah, Sern Yih ^a   Lawford, Bruce R ^a,b   Young, Ross McD ^a   Morris, C Phillip ^a   Voisey, Joanne ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Depression; NOS1AP; Polymorphism; Psychiatric phenotypes; Schizophrenia; SNP

Indexed keywords

ADAPTOR PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE 1 ADAPTOR PROTEIN; UNCLASSIFIED DRUG; NOS1AP PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP; CASE CONTROL STUDY; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PSYCHOLOGY; SEXUAL DEVELOPMENT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 84941756997     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.08.069     Document Type: Article

References (40)

1. J.H. Abramson WINPEPI (PEPI-for-Windows): computer programs for epidemiologists Epidemiol. Perspect. Innov. 1 2004 6
2. M. Banasr, G.M. Chowdhury, R. Terwilliger, S.S. Newton, R.S. Duman, K.L. Behar, and G. Sanacora Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole Mol. Psychiatry 15 2010 501 511
3. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc. Ser. B: Stat. Methodol. 57 1995 289 300
4. J.E. Brenman, D.S. Chao, S.H. Gee, A.W. McGee, S.E. Craven, D.R. Santillano, Z. Wu, F. Huang, H. Xia, M.F. Peters, S.C. Froehner, and D.S. Bredt Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains Cell 84 1996 757 767
5. L.M. Brzustowicz, J.E. Hayter, K.A. Hodgkinson, E.W. Chow, and A.S. Bassett Fine mapping of the schizophrenia susceptibility locus on chromosome 1q22 Hum. Hered. 54 2002 199 209
6. L.M. Brzustowicz, K.A. Hodgkinson, E.W. Chow, W.G. Honer, and A.S. Bassett Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22 Science 288 2000 678 682
7. D.J. Castle, A. Jablensky, J.J. McGrath, V. Carr, V. Morgan, A. Waterreus, G. Valuri, H. Stain, P. McGuffin, and A. Farmer The diagnostic interview for psychoses (DIP): development, reliability and applications Psychol. Med. 36 2006 69 80
8. J.H. Cheah, S.F. Kim, L.D. Hester, K.W. Clancy, S.E. Patterson 3rd, V. Papadopoulos, and S.H. Snyder NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1 Neuron 51 2006 431 440
9. J.T. Coyle, G. Tsai, and D. Goff Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia Ann. NY Acad. Sci. 1003 2003 318 327
10. R. Delorme, C. Betancur, I. Scheid, H. Anckarsater, P. Chaste, S. Jamain, F. Schuroff, G. Nygren, E. Herbrecht, A. Dumaine, M.C. Mouren, M. Rastam, M. Leboyer, C. Gillberg, and T. Bourgeron Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls BMC Med. Genet. 11 2010 108
11. A. Dhir, and S.K. Kulkarni Nitric oxide and major depression Nitric Oxide 24 2011 125 131
12. M.V. Doucet, A. Harkin, and K.K. Dev The PSD-5/nNOS complex: new drugs for depression? Pharmacol. Ther. 133 2012 218 229
13. M.V. Doucet, H. Levine, K.K. Dev, and A. Harkin Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice Neuropsychopharmacology 38 2013 1575 1584
14. C. Fang, W. Tang, R.Q. Tang, L. Wang, G.Q. Zhou, K. Huang, X.W. Li, G.Y. Feng, M. He, L.Z. Du, S.M. Zhu, Y.L. Xing, H. Sang, L. He, and Y.Y. Shi Family-based association studies of CAPON and schizophrenia in the Chinese Han population Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1210 1213
15. M. Fang, S.R. Jaffrey, A. Sawa, K. Ye, X. Luo, and S.H. Snyder Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON Neuron 28 2000 183 193
16. F. Freudenberg, A. Alttoa, and A. Reif Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders Genes Brain Behav. 14 2015 46 63
17. S.L. Gourley, J.W. Espitia, G. Sanacora, and J.R. Taylor Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice Psychopharmacology 219 2012 805 814
18. N.M. Hadzimichalis, M.L. Previtera, M.P. Moreau, B. Li, G.H. Lee, A.M. Dulencin, P.G. Matteson, S. Buyske, J.H. Millonig, L.M. Brzustowicz, and B.L. Firestein NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia Schizophr. Res. 124 2010 248 250
19. International HapMap Consortium The international HapMap project Nature 426 2003 789 796
20. S.R. Jaffrey, A.M. Snowman, M.J. Eliasson, N.A. Cohen, and S.H. Snyder CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95 Neuron 20 1998 115 124
21. B. Kremeyer, J. Garcia, H. Kymalainen, N. Wratten, G. Restrepo, C. Palacio, A.L. Miranda, C. Lopez, M. Restrepo, G. Bedoya, L.M. Brzustowicz, J. Ospina-Duque, M.P. Arbelaez, and A. Ruiz-Linares Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate Hum. Hered. 67 2009 163 173
22. U.E. Lang, I. Puls, D.J. Muller, N. Strutz-Seebohm, and J. Gallinat Molecular mechanisms of schizophrenia Cell Physiol. Biochem. 20 2007 687 702
23. B.R. Lawford, C.P. Morris, C.D. Swagell, I.P. Hughes, R.M. Young, and J. Voisey NOS1AP is associated with increased severity of PTSD and depression in untreated combat veterans J. Affect. Disord. 147 2013 87 93
24. L.L. Li, V. Ginet, X. Liu, O. Vergun, M. Tuittila, M. Mathieu, C. Bonny, J. Puyal, A.C. Truttmann, and M.J. Courtney The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death J. Neurosci. 33 2013 8185 8201
25. K. Merritt, P. McGuire, and A. Egerton Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis Front. Psychiatry 4 2013 151
26. Y.S. Mineur, M.R. Picciotto, and G. Sanacora Antidepressant-like effects of ceftriaxone in male C57BL/6J mice Biol. Psychiatry 61 2007 250 252
27. V.A. Morgan, A. Waterreus, A. Jablensky, A. Mackinnon, J.J. McGrath, V. Carr, R. Bush, D. Castle, M. Cohen, C. Harvey, C. Galletly, H.J. Stain, A. Neil, P. McGorry, B. Hocking, S. Shah, and S. Saw People Living with Psychotic Illness 2010: Report on the Second Australian National Survey 2011 Department of Health and Ageing Canberra
28. P.I. Nedvetsky, W.C. Sessa, and H.H. Schmidt There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling Proc. Natl. Acad. Sci. USA 99 2002 16510 16512
29. K.K. Nicodemus, S. Marenco, A.J. Batten, R. Vakkalanka, M.F. Egan, R.E. Straub, and D.R. Weinberger Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk Mol. Psychiatry 13 2008 873 877
30. A. Oksuzyan, E. Crimmins, Y. Saito, A. O'Rand, J.W. Vaupel, and K. Christensen Cross-national comparison of sex differences in health and mortality in Denmark, Japan and the US Eur. J. Epidemiol. 25 2010 471 480
31. Ott, J., 1988. Utility programs for analysis of genetic linkage, program, hwe version 1.10. Columbia University, New York.
32. V. Puri, A. McQuillin, S. Thirumalai, J. Lawrence, R. Krasucki, K. Choudhury, S. Datta, S. Kerwin, D. Quested, N. Bass, J. Pimm, G. Lamb, H. Moorey, G. Kandasami, A. Badacsonyi, K. Kelly, J. Morgan, B. Punukollu, H. Nadeem, D. Curtis, and H.M. Gurling Failure to confirm allelic association between markers at the CAPON gene locus and schizophrenia in a British sample Biol. Psychiatry 59 2006 195 197
33. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci Nature 511 2014 421 427
34. N. Shiraishi, N. Watanabe, Y. Kinoshita, A. Kaneko, S. Yoshida, T.A. Furukawa, and T. Akechi Brief psychoeducation for schizophrenia primarily intended to change the cognition of auditory hallucinations: an exploratory study J Nerv. Ment. Dis. 202 2014 35 39
35. D. Stenberg Neuroanatomy and neurochemistry of sleep Cell Mol. Life Sci. 64 2007 1187 1204
36. H. Weber, D. Klamer, F. Freudenberg, S. Kittel-Schneider, O. Rivero, C.J. Scholz, J. Volkert, J. Kopf, J. Heupel, S. Herterich, R. Adolfsson, A. Alttoa, A. Post, H. Grussendorf, A. Kramer, A. Gessner, B. Schmidt, S. Hempel, C.P. Jacob, J. Sanjuan, M.D. Molto, K.P. Lesch, C.M. Freitag, L. Kent, and A. Reif The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis Eur. Neuropsychopharmacol. 24 2014 65 85
37. N.S. Wratten, H. Memoli, Y. Huang, A.M. Dulencin, P.G. Matteson, M.A. Cornacchia, M.A. Azaro, J. Messenger, J.E. Hayter, A.S. Bassett, S. Buyske, J.H. Millonig, V.J. Vieland, and L.M. Brzustowicz Identification of a schizophrenia-associated functional noncoding variant in NOS1AP Am. J. Psychiatry 166 2009 434 441
38. B. Xu, N. Wratten, E.I. Charych, S. Buyske, B.L. Firestein, and L.M. Brzustowicz Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder PLoS Med. 2 2005 e263
39. Y. Zheng, H. Li, W. Qin, W. Chen, Y. Duan, Y. Xiao, C. Li, J. Zhang, X. Li, G. Feng, and L. He Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population Biochem. Biophys. Res. Commun. 328 2005 809 815
40. L.J. Zhu, T.Y. Li, C.X. Luo, N. Jiang, L. Chang, Y.H. Lin, H.H. Zhou, C. Chen, Y. Zhang, W. Lu, L.Y. Gao, Y. Ma, Q.G. Zhou, Q. Hu, X.L. Hu, J. Zhang, H.Y. Wu, and D.Y. Zhu CAPON-nNOS coupling can serve as a target for developing new anxiolytics Nat. Med. 20 2014 1050 1054